7101 - 7150 of 9036 Results
Title
Year
-
OPENTitle: Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/795294Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/795294.pdfCitation Count: 33
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial2011RESTRICTEDTitle: AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 4Start Page: 309End Page: 319Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70039-4Citation Count: 667
- Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia2021OPENTitle: Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementiaJournal Name: CortexPublisher: Elsevier BVVol: 139Issue #:Start Page: 99End Page: 115Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2021.03.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8119343Citation Count: 39
-
OPENTitle: Identification of a Putative α-synuclein Radioligand Using an in silico Similarity SearchJournal Name: Molecular Imaging and BiologyPublisher: Springer Science and Business Media LLCVol: 25Issue #: 4Start Page: 704End Page: 719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11307-023-01814-9Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10527666/pdf/nihms-1908506.pdfCitation Count: 16
-
OPENTitle: LRRK2 activation in idiopathic Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 451Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5429Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6344941Citation Count: 599
-
OPENTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 38
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
-
OPENTitle: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort ExperienceJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 665End Page: 675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191901Best OA location URL: https://escholarship.org/uc/item/1rb4t3mzCitation Count: 61
-
OPENTitle: Palliative Care and Parkinson's Disease: Time to Move Beyond CancerJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1325End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28556Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8217287Citation Count: 24
-
OPENTitle: Using Qualitative Methods to Understand Physical Activity and Weight Management Among Bangladeshis in New York City, 2013Journal Name: Preventing Chronic DiseasePublisher: Centers for Disease Control and Prevention - Preventing Chronic DiseaseVol: 13Issue #:Start Page: E87End Page: E87Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.5888/pcd13.160077Best OA location URL: https://www.cdc.gov/pcd/issues/2016/pdf/16_0077.pdfCitation Count: 23
-
OPENTitle: Home-Based Augmented Reality Gait-and-Balance Therapy in Parkinson Disease: An Examination of Exercise IntensityJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2025.12.008Best OA location URL: https://doi.org/10.1016/j.apmr.2025.12.008Citation Count: 1
-
OPENTitle: Intact working memory in non‐manifesting LRRK2 carriers – an fMRI studyJournal Name: European Journal of NeurosciencePublisher: WileyVol: 43Issue #: 1Start Page: 106End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13120Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13120Citation Count: 20
- Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease2018RESTRICTEDTitle: Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 190Issue #:Start Page: 94End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.01.021Citation Count: 27
-
OPENTitle: TBK1 Induces the Formation of Optineurin Filaments That Condensate with Polyubiquitin and LC3 for Cargo SequestrationJournal Name: Advanced SciencePublisher: WileyVol: 13Issue #: 16Start Page: e09927End Page: e09927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/advs.202509927Best OA location URL: https://doi.org/10.1002/advs.202509927Citation Count: 0
- The Parkinson's Progression Markers Initiative: Why Then? Why Now?2026RESTRICTEDTitle: The Parkinson's Progression Markers Initiative: Why Then? Why Now?Journal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78192Citation Count: 0
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 32
-
OPENTitle: Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple SclerosisJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 80Issue #: 1Start Page: 62End Page: 72Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.biopsych.2015.11.022Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/46558917/1_s2.0_S0006322315010252_main.pdfCitation Count: 146
-
OPENTitle: Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodiesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 15End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0010-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0010-2Citation Count: 145
-
OPENTitle: Rare variants in LRRK1 and Parkinson's diseaseJournal Name: neurogeneticsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 49End Page: 57Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s10048-013-0383-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10048-013-0383-8.pdfCitation Count: 32
-
OPENTitle: Neuropathology of Beta-propeller protein associated neurodegeneration (BPAN): a new tauopathyJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 39End Page: 39Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-015-0221-3Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-015-0221-3Citation Count: 55
-
OPENTitle: A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1Journal Name: CellPublisher: Elsevier BVVol: 154Issue #: 4Start Page: 737End Page: 747Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2013.07.030Best OA location URL: http://www.cell.com/article/S009286741300901X/pdfCitation Count: 271
-
OPENTitle: Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvationJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 441Issue #: 4Start Page: 862End Page: 866Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.bbrc.2013.10.159Best OA location URL: https://doi.org/10.1016/j.bbrc.2013.10.159Citation Count: 86
-
OPENTitle: Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult miceJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 227Issue #: 2Start Page: 237End Page: 251Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.11.010Best OA location URL: https://pure.rug.nl/ws/files/2521820/2011ExpNeurolChertoff.pdfCitation Count: 69
-
OPENTitle: Visual Hallucinations in Eye Disease and Lewy Body DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 24Issue #: 5Start Page: 350End Page: 358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2015.10.007Best OA location URL: http://www.ajgponline.org/article/S1064748115002687/pdfCitation Count: 34
-
OPENTitle: Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseasesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 38Issue #:Start Page: 214.e7End Page: 214.e10Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.10.028Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2015.10.028Citation Count: 90
-
OPENTitle: Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic casesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 58Issue #:Start Page: 183End Page: 190Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2013.05.017Best OA location URL: http://infoscience.epfl.ch/record/189244Citation Count: 59
- Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study2015OPENTitle: Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 6Start Page: 650End Page: 653Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.02.026Citation Count: 383
-
OPENTitle: Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brainJournal Name: Journal of NeurochemistryPublisher: WileyVol: 135Issue #: 6Start Page: 1242End Page: 1256Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/jnc.13369Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13369Citation Count: 70
- Olfaction inParkinsingle and compound heterozygotes in a cohort of young onset Parkinson's disease patients2015RESTRICTEDTitle: Olfaction inParkinsingle and compound heterozygotes in a cohort of young onset Parkinson's disease patientsJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 134Issue #: 4Start Page: 271End Page: 276Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ane.12538Citation Count: 24
-
OPENTitle: Integrative Pathway-Based Approach for Genome-Wide Association Studies: Identification of New Pathways for Rheumatoid Arthritis and Type 1 DiabetesJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 10Start Page: e78577End Page: e78577Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0078577Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0078577&type=printableCitation Count: 10
-
OPENTitle: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 17Start Page: 5625End Page: 5629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104Best OA location URL: http://hdl.handle.net/10871/35665Citation Count: 151
-
OPENTitle: Characterization of TAE684 as a potent LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 5Start Page: 1864End Page: 1869Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.01.084Best OA location URL: http://hdl.handle.net/10871/35667Citation Count: 88
-
OPENTitle: Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 6Start Page: 1514.e1End Page: 1514.e12Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.01.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2014.01.010Citation Count: 50
-
OPENTitle: Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicityJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 22Issue #: 2Start Page: 328End Page: 344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/dds431Best OA location URL: https://academic.oup.com/hmg/article-pdf/22/2/328/1857445/dds431.pdfCitation Count: 74
-
OPENTitle: Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegenerationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 17Start Page: 4621End Page: 4638Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddu178Best OA location URL: https://academic.oup.com/hmg/article-pdf/23/17/4621/2215861/ddu178.pdfCitation Count: 174
- Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research2012OPENTitle: Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease ResearchJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 8Start Page: e43099End Page: e43099Publication Date:Open Access(OA) Status: OPENLicense: cc0, cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0043099Best OA location URL: https://escholarship.org/uc/item/0hr9m7btCitation Count: 141
-
OPENTitle: Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)Journal Name: Current NeuropharmacologyPublisher: Bentham Science Publishers Ltd.Vol: 11Issue #: 1Start Page: 59End Page: 79Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/157015913804999469Best OA location URL: http://europepmc.org/articles/PMC3580793Citation Count: 127
-
OPENTitle: A Tangled Web – Tau and Sporadic Parkinson's DiseaseJournal Name: Frontiers in PsychiatryPublisher: Frontiers Media SAVol: 1Issue #:Start Page: 150End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fpsyt.2010.00150Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2010.00150/pdfCitation Count: 32
-
OPENTitle: Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseasesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 15Start Page: 3500End Page: 3512Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/dds161Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3392107Citation Count: 236
-
OPENTitle: The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBACJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 617Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.aav1256Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7279956Citation Count: 25
-
OPENTitle: Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on ‘effective’ connectivityJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 4Start Page: 1130End Page: 1144Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu027Best OA location URL: https://academic.oup.com/brain/article-pdf/137/4/1130/13799493/awu027.pdfCitation Count: 220
-
OPENTitle: CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 10Start Page: 690End Page: 695Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318249f683Best OA location URL: https://hdl.handle.net/2108/99911Citation Count: 391
-
OPENTitle: Role of Elongation and Secondary Pathways in S6 Amyloid Fibril GrowthJournal Name: Biophysical JournalPublisher: Elsevier BVVol: 102Issue #: 9Start Page: 2167End Page: 2175Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bpj.2012.03.047Best OA location URL: http://www.cell.com/article/S0006349512003888/pdfCitation Count: 35
-
OPENTitle: Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 111Issue #: 7Start Page: 2626End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1318306111Best OA location URL: https://www.pnas.org/content/pnas/111/7/2626.full.pdfCitation Count: 367
-
OPENTitle: Large-scale replication and heterogeneity in Parkinson disease genetic lociJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 7Start Page: 659End Page: 667Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318264e353Best OA location URL: https://n.neurology.org/content/neurology/79/7/659.full.pdfCitation Count: 131
-
OPENTitle: Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar DegenerationJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 68Issue #: 4Start Page: 488End Page: 488Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2011.53Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3160280Citation Count: 121
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions2010OPENTitle: Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusionsJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 42Issue #: 3Start Page: 234End Page: 239Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ng.536Best OA location URL: http://doi.org/10.1038/ng.536Citation Count: 609
-
OPENTitle: Genetic variability at the PARK16 locusJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 12Start Page: 1356End Page: 1359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ejhg.2010.125Best OA location URL: https://www.nature.com/articles/ejhg2010125.pdfCitation Count: 94
-
OPENTitle: Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page: 440End Page: 440Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-sa, cc-by-nc-saDOI - Digital Object Identifier: 10.1038/ncomms1453Best OA location URL: https://www.nature.com/articles/ncomms1453.pdfCitation Count: 497
-
OPENTitle: Widespread sex differences in gene expression and splicing in the adult human brainJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 2771End Page: 2771Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/ncomms3771Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/75c8359f-d7e0-4c9d-8d86-c004995b7417Citation Count: 338